SLC5A2 and type 2 diabetes mellitus: Drugs that can induce either direct or indirect activation of AMPK include metformin, salicate and canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor that has been recently approved for the treatment of type 2 diabetes [23,41,84].